Acetylation of HDAC1 and degradation of SIRT1 form a positive feedback loop to regulate p53 acetylation during heat-shock stress

Cell Death and Disease

Volumn 6, Issue 5, 2015, Pages

  Yang, H ^a   Yan, B ^a   Liao, D ^a   Huang, S ^a   Qiu, Y ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 1; PROTEASOME; PROTEIN P53; SIRTUIN 1; HDAC1 PROTEIN, HUMAN; PROTEIN BINDING; SIRT1 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

ARTICLE; CELL STRESS; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DEACETYLATION; GENE EXPRESSION; HEAT SHOCK; HISTONE ACETYLATION; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; ACETYLATION; HCT 116 CELL LINE; HEAT SHOCK RESPONSE; HT-29 CELL LINE; HUMAN; MCF-7 CELL LINE; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

ACETYLATION; CELL LINE, TUMOR; HCT116 CELLS; HEAT-SHOCK RESPONSE; HISTONE DEACETYLASE 1; HT29 CELLS; HUMANS; MCF-7 CELLS; PROTEIN BINDING; SIRTUIN 1; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84966991190     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.106     Document Type: Article

References (58)

1. Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009;325:834-840.
2. Cress WD, Seto E. Histone deacetylases, transcriptional control, and cancer. J Cell Physiol 2000;184:1-16.
3. Blander G, Guarente L. The Sir2 family of protein deacetylases. Annu Rev Biochem 2004;73:417-435.
4. Haigis MC, Guarente LP. Mammalian sirtuins - emerging roles in physiology, aging, and calorie restriction. Genes Dev 2006;20:2913-2921.
5. Saunders LR, Verdin E. Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene 2007;26:5489-5504.
6. Cho Y, Griswold A, Campbell C, Min KT. Individual histone deacetylases in Drosophila modulate transcription of distinct genes. Genomics 2005;86:606-617.
7. Foglietti C, Filocamo G, Cundari E, De Rinaldis E, Lahm A, Cortese R et al. Dissecting the biological functions of Drosophila histone deacetylases by RNA interference and transcriptional profiling. J Biol Chem 2006;281:17968-17976.
8. Yang XJ, Seto E. The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat Rev Mol Cell Biol 2008;9:206-218.
9. Segre CV, Chiocca S. Regulating the regulators: the post-translational code of class I HDAC1 and HDAC2. J Biomed Biotechnol 2011;2011:690848.
10. Osoata GO, Yamamura S, Ito M, Vuppusetty C, Adcock IM, Barnes PJ et al. Nitration of distinct tyrosine residues causes inactivation of histone deacetylase 2. Biochem Biophys Res Commun 2009;384:366-371.
11. Qiu Y, Zhao Y, Becker M, John S, Parekh BS, Huang S et al. HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription. Mol Cell 2006;22:669-679.
12. Oh YM, Kwon YE, Kim JM, Bae SJ, Lee BK, Yoo SJ et al. Chfr is linked to tumour metastasis through the downregulation of HDAC1. Nat Cell Biol 2009;11:295-302.
13. Dobbin MM, Madabhushi R, Pan L, Chen Y, Kim D, Gao J et al. SIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons. Nat Neurosci 2013;16:1008-1015.
14. Yang T, Jian W, Luo Y, Fu X, Noguchi C, Bungert J et al. Acetylation of histone deacetylase 1 regulates NuRD corepressor complex activity. J Biol Chem 2012;287:40279-40291.
15. Luo Y, Jian W, Stavreva D, Fu X, Hager G, Bungert J et al. Trans-regulation of histone deacetylase activities through acetylation. J Biol Chem 2009;284:34901-34910.
16. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000;408:307-310.
17. el-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994;54:1169-1174.
18. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999;13:1501-1512.
19. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51:6304-6311.
20. Ito A, Lai CH, Zhao X, Saito S, Hamilton MH, Appella E et al. P300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J 2001;20:1331-1340.
21. Gu W, Roeder RG. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 1997;90:595-606.
22. Sykes SM, Mellert HS, Holbert MA, Li K, Marmorstein R, Lane WS et al. Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol Cell 2006;24:841-851.
23. Kruse JP, Gu W. SnapShot: p53 posttranslational modifications. Cell 2008;133:930-930 e931.
24. Dai C, Gu W. P53 post-translational modification: deregulated in tumorigenesis. Trends Mol Med 2010;16:528-536.
25. Ito A, Kawaguchi Y, Lai CH, Kovacs JJ, Higashimoto Y, Appella E et al. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J 2002;21:6236-6245.
26. Brooks CL, Gu W. The impact of acetylation and deacetylation on the p53 pathway. Protein Cell 2011;2:456-462.
27. Bode AM, Dong Z. Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 2004;4:793-805.
28. Brooks CL, Gu W. Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 2003;15:164-171.
29. Lee JT, Gu W. SIRT1: regulator of p53 deacetylation. Genes Cancer 2013;4:112-117.
30. Luo J, Su F, Chen D, Shiloh A, Gu W. Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 2000;408:377-381.
31. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A et al. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 2001;107:137-148.
32. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK et al. hSIR2 (SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001;107:149-159.
33. Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, Patel P et al. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA 2003;100:10794-10799.
34. Lain S, Hollick JJ, Campbell J, Staples OD, Higgins M, Aoubala M et al. Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator. Cancer Cell 2008;13:454-463.
35. Nitta M, Okamura H, Aizawa S, Yamaizumi M. Heat shock induces transient p53-dependent cell cycle arrest at G1/S. Oncogene 1997;15:561-568.
36. Matsumoto H, Shimura M, Omatsu T, Okaichi K, Majima H, Ohnishi T. P53 proteins accumulated by heat stress associate with heat shock proteins HSP72/HSC73 in human glioblastoma cell lines. Cancer Lett 1994;87:39-46.
37. Nagashima M, Shiseki M, Miura K, Hagiwara K, Linke SP, Pedeux R et al. DNA damageinducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53. Proc Natl Acad Sci USA 2001;98:9671-9676.
38. Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A et al. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 1998;12:2831-2841.
39. Ito A, Kawaguchi Y, Lai C-H, Kovacs JJ, Higashimoto Y, Appella E et al. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J 2002;21:6236-6245.
40. Yang H, Salz T, Zajac-Kaye M, Liao D, Huang S, Qiu Y. Overexpression of histone deacetylases in cancer cells is controlled by interplay of transcription factors and epigenetic modulators. FASEB J 2014;28:4265-4279.
41. Yang H, Pinello CE, Luo J, Li D, Wang Y, Zhao LY et al. Small-molecule inhibitors of acetyltransferase p300 identified by high-throughput screening are potent anticancer agents. Mol Cancer Ther 2013;12:610-620.
42. Caito S, Rajendrasozhan S, Cook S, Chung S, Yao H, Friedman AE et al. SIRT1 is a redoxsensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress. FASEB J 2010;24:3145-3159.
43. Kwon HS, Ott M. The ups and downs of SIRT1. Trends Biochem Sci 2008;33:517-525.
44. Yang Y, Fu W, Chen J, Olashaw N, Zhang X, Nicosia SV et al. SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress. Nat Cell Biol 2007;9:1253-1262.
45. Zupkovitz G, Grausenburger R, Brunmeir R, Senese S, Tischler J, Jurkin J et al. The cyclindependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation. Mol Cell Biol 2010;30:1171-1181.
46. Yamaguchi T, Cubizolles F, Zhang Y, Reichert N, Kohler H, Seiser C et al. Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression. Genes Dev 2010;24:455-469.
47. Lagger G, Doetzlhofer A, Schuettengruber B, Haidweger E, Simboeck E, Tischler J et al. The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene. Mol Cell Biol 2003;23:2669-2679.
48. Lin YC, Lin JH, Chou CW, Chang YF, Yeh SH, Chen CC. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2. Cancer Res 2008;68:2375-2383.
49. Gui CY, Ngo L, Xu WS, Richon VM, Marks PA. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. Proc Natl Acad Sci USA 2004;101:1241-1246.
50. Ram O, Goren A, Amit I, Shoresh N, Yosef N, Ernst J et al. Combinatorial patterning of chromatin regulators uncovered by genome-wide location analysis in human cells. Cell 2011;147:1628-1639.
51. Brooks CL, Gu W. New insights into p53 activation. Cell Res 2010;20:614-621.
52. Deng CX. SIRT1, is it a tumor promoter or tumor suppressor? Int J Biol Sci 2009;5:147-152.
53. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004;23:2369-2380.
54. Wang RH, Zheng Y, Kim HS, Xu X, Cao L, Luhasen T et al. Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis. Mol Cell 2008;32:11-20.
55. Wang RH, Sengupta K, Li C, Kim HS, Cao L, Xiao C et al. Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell 2008;14:312-323.
56. Gao Z, Zhang J, Kheterpal I, Kennedy N, Davis RJ, Ye J. Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun. N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity. J Biol Chem 2011;286:22227-22234.
57. Humphrey GW, Wang Y, Russanova VR, Hirai T, Qin J, Nakatani Y et al. Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1. J Biol Chem 2001;276:6817-6824.
58. Nakatani Y, Ogryzko V. Immunoaffinity purification of mammalian protein complexes. Methods Enzymol 2003;370:430-444.